Senolytics
Idiopathic Pulmonary Fibrosis · Sequential: D+Q clears senescent cells, RSPO3 expands AEC2 pool
Mechanism
Sequential: D+Q clears senescent cells, RSPO3 expands AEC2 pool
Development stage
Concept/Preclinical
Evidence level
Rational Combination
Developer
UCSF / Mayo
Overview
Novel sequential protocol. Highest regenerative potential of any near-term strategy.
Explore related
Medical disclaimer. This page summarizes research about Senolytics for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.